Dr. Mark Poznansky was interviewed live on All in with Chris Hayes MSNBC, April 14 to discuss vaccines during the COVID-19 pandemic. Chris acknowledged that Dr. Poznansky is beginning research on a vaccine at the Vaccine and Immunotherapy Center at MGH and the discussion was based around the timeline for a vaccine and the efficacy of a vaccine before it can be used on millions of people worldwide. Dr. Poznansky also said that links with industry are crucial in order to move forward with efficacy studies and manufacturing after the initial vaccine design and noted that we are collaborating with Voltron, Inc and Hoth Therapeutics for this purpose.
The Scientific American article makes for very interesting reading – written by William A. Haseltine a mentor of Mark Poznansky, when he was doing research in the HIV field.
“In the event of any infectious disease outbreak, our minds turn to vaccines—and they do so for good reason. They’re safe, relatively expensive and have worked well for diseases including smallpox, polio, yellow fever, and, most recently, Ebola.
Will a vaccine come as easily for the novel coronavirus? The answer is maybe yes, maybe not. The “maybe yes” comes from the observation that in animal studies, coronaviruses stimulate strong immune responses, which seem capable of knocking out the virus. Recovery from COVID-19 may be in large part due to effective immune response. The “maybe not” comes from evidence just as strong, at least with earlier SARS and MERS viruses, that natural immunity to these viruses is short-lived. In fact, some animals can be reinfected with the very same strain that caused infection in the first place…”
VIC Senior Scientist Huabiao Chen, PhD assists the Chinese-American (CAN-WIN) community in Winchester in the distribution of much need PPE to local hospitals and frontline workers in the community.
This Thursday, Dr. Mark Poznansky and Dr. Patrick Reeves from VIC will join Boston’s Hackers and Hustlers Meetup for a virtual Town Hall. They’ll cover how to implement both immediate and mid/long-term solutions in the fight against COVID-19.
If you’d like to hear first-hand from experts in immunotherapy and have the chance to ask your own questions, please join on Thursday at 6pm ET. View MeetUp details below.